(Q40024233)

English

Anti-tumor activity and tumor vessel normalization by the vascular endothelial growth factor receptor tyrosine kinase inhibitor KRN951 in a rat peritoneal disseminated tumor model.

scientific article published on 15 January 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18201272%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Anti-tumor activity and tumor vessel normalization by the vascular endothelial growth factor receptor tyrosine kinase inhibitor KRN951 in a rat peritoneal disseminated tumor model (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18201272%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

0 references

Kazuhide Nakamura

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18201272%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Eri Taguchi

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18201272%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Toru Miura

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18201272%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Masabumi Shibuya

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18201272%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Toshiyuki Isoe

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18201272%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

15 January 2008

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18201272%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18201272%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

99

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18201272%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

623-630

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18201272%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18201272%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00724.X

21 January 2018

Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00724.X

21 January 2018

Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00724.X

21 January 2018

Vascular endothelial growth factor is a secreted angiogenic mitogen

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00724.X

21 January 2018

Tyrosine kinase inhibitors of vascular endothelial growth factor receptors in clinical trials: current status and future directions.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00724.X

21 January 2018

Soluble markers for the assessment of biological activity with PTK787/ZK 222584 (PTK/ZK), a vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor in patients with advanced colorectal cancer from two phase I trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00724.X

21 January 2018

Phase 2 studies of sunitinib and AG013736 in patients with cytokine-refractory renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00724.X

21 January 2018

A review of the latest clinical compounds to inhibit VEGF in pathological angiogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00724.X

21 January 2018

A Phase I study of escalating doses of the tyrosine kinase inhibitor semaxanib (SU5416) in combination with irinotecan in patients with advanced colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00724.X

21 January 2018

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00724.X

21 January 2018

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00724.X

21 January 2018

Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00724.X

21 January 2018

Bevacizumab in the treatment of colorectal cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00724.X

21 January 2018

The present and future of angiogenesis-directed treatments of colorectal cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00724.X

21 January 2018

Malignant ascites. Clinical and experimental observations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00724.X

21 January 2018

KRN951, a highly potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, has antitumor activities and affects functional vascular properties.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00724.X

21 January 2018

A new rat colon cancer cell line metastasizes spontaneously: biologic characteristics and chemotherapeutic response

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00724.X

21 January 2018

Angiogenic vascular growth in the rat peritoneal disseminated tumor model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00724.X

21 January 2018

In vivo models of angiogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00724.X

21 January 2018

Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00724.X

21 January 2018

Inhibition of peritoneal dissemination of ovarian cancer by tyrosine kinase receptor inhibitor SU6668 (TSU-68).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00724.X

21 January 2018

Vascular endothelial growth factor immunoneutralization plus Paclitaxel markedly reduces tumor burden and ascites in athymic mouse model of ovarian cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00724.X

21 January 2018

Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00724.X

21 January 2018

Vascular endothelial growth factor trap combined with paclitaxel strikingly inhibits tumor and ascites, prolonging survival in a human ovarian cancer model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00724.X

21 January 2018

Blood-based biomarkers of SU11248 activity and clinical outcome in patients with metastatic imatinib-resistant gastrointestinal stromal tumor.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00724.X

21 January 2018

Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00724.X

21 January 2018

Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00724.X

21 January 2018

Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00724.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40024233&oldid=1478097553"